CIK 0001359931 · Non-accelerated filer<br>Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 204580525
- Phone
- 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- 8-A12B Other Registration of Securities
- CERTNAS Other Certification by the Nasdaq Stock Market
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- REGDEX Other REGDEX
- REGDEX Other REGDEX
- REGDEX/A Other REGDEX/A
- REGDEX/A Other REGDEX/A
- REGDEX Other REGDEX
Page 4 of 4 · 79 filings